Lance Berman, Chief Medical Officer and SVP at Relypsa Inc (RLYP), sold 5,000 shares at $37.82 ($191K) on 2015-02-24, disclosed to the SEC on 2015-02-25.
Scheduled sale ($191k) by Chief Medical Officer and SVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.82 | 2,700 | $102K | 53.5% |
| 2 | $38.63 | 2,300 | $89K | 46.5% |
| Total | $38.19 avg | 5,000 | $191K | 100% |
| Filing → |
| RLYP | SELL | 2014-12-02 | $125K | — | Filing → |
| RLYP | SELL | 2014-11-26 | $750K | — | Filing → |
| RLYP | SELL | 2014-09-25 | $110K | — | Filing → |